Latest News:

ar deelen fr it

TIF

Delegation visit to Azerbaijan – 22-24 May 2019

...
Bluebird puts €1.58m price on gene therapy Zynteglo

Bluebird bio Inc. set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 mi...
Sickle Cell Disease Update

CRISPR gene editing (SCD) Update: 30 May 2019 No update available. Update: 29 March 20...
Apotransferrin

Update: 30 May 2019 Apotransferrinhas a physiological role in the transportation and distrib...
FROM PUMP TO PILL by Chanapa Tantibanchachai

Winner Story #1 – International Thalassaemia Day 2018 »As I reflect on my past, present and f...

Highlights APERÇUS IN EVIDENZA أخبار مهمة Κυριότερα Σημεία Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونية للاتحاد الدولي للثلاسيمياΗλεκτρονική ΑκαδημίαTIF e-Akademie

ConferencesConférencesConferenzeالمؤتمراتΣυνέδριαKonferenzen

Patients' StoriesRécits de patientsStorie di pazientiقصص المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب الإكلينكية Ενημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

Thalassaemia Patients ConnectInterconnexion des patients atteints de thalassémiePazienti talassemici connessiالتواصل بين مرضى ’الثلاسيميا’Πλατφόρμα Thalassaemia Patients ConnectThalassämie-Patienten Connect

CommunicationsCommunicationsComunicazioniWORDΜέσα επικοινωνίαςKommunikation

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer